Filing Flows › ASP Isotopes (ASPI) › Q2 2026 › vs Q1 2026
ASP Isotopes (ASPI) Q2 2026 vs Q1 2026 (quarter over quarter)
ASP Isotopes's revenue rose $943K (+23%) from $4.2M in Q1 2026 to $5.1M in Q2 2026. The biggest changes: Product +$543K (+14%); Collaboration Revenue +$400K (+200%).
ASP Isotopes, Q2 2026: revenue $5.1M (+328% year over year), operating margin -667.5%, net loss $34.0M, operating cash flow −$23.3M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product | $4.5M | $4.0M | $543K | +14% |
| Collaboration Revenue | $600K | $200K | $400K | +200% |
| Revenue | $5.1M | $4.2M | $943K | +23% |
| Other income, net | $105K | $17.7M | −$17.6M | -99% |
| Income tax benefit | $97K | $31K | $66K | +213% |
| Net loss | $34.0M | $7.1M | $26.9M | +377% |
| Costs & expenses | $39.3M | $29.1M | $10.2M | +35% |
| Operating costs | $39.3M | $29.1M | $10.2M | +35% |
| Cost of revenue | $3.6M | $2.5M | $1.1M | +45% |
| Research & development | $6.8M | $5.3M | $1.6M | +30% |
| General & admin | $28.9M | $21.3M | $7.6M | +36% |
| Operating cash sources | $34.0M | $7.1M | $26.9M | +377% |
| Depreciation & amortization | $1.2M | $3.1M | −$1.9M | -61% |
| Share-based compensation | $4.5M | $4.4M | $130K | +3% |
| Working capital & other | $4.9M | −$18.1M | $23.0M | — |
| Cash used in operations | $23.3M | $17.8M | $5.6M | +31% |
| Net loss absorbed | $34.0M | $7.1M | $26.9M | +377% |
Questions
How much did ASP Isotopes's revenue grow quarter over quarter in Q2 2026?
ASP Isotopes's revenue rose $943K (+23%) from $4.2M in Q1 2026 to $5.1M in Q2 2026.
What drove ASP Isotopes's revenue change in Q2 2026?
Product +$543K (+14%); Collaboration Revenue +$400K (+200%).